One of the biggest problems with our whole prescription drug system--and I think all five of you know this--is how opaque it is.

I think they do it intentionally wrong.

But they are dropping out.

I have been working on this my whole career, pushing for Medicare price negotiations, pushing to crack down on drug company price-gouging.

One of the biggest problems with our whole prescription drug system--and I think all five of you know this--is how opaque it is.

With the Inflation Reduction Act, we stood up to big pharma and dark money and finally began to take action to bring down the cost of prescription drugs.

I called the administration last year to finalize its DIR fee reform proposal to help lower drug costs for seniors.

I have been working on this my whole career, pushing for Medicare price negotiations, pushing to crack down on drug company price-gouging.

They increased liquidity, promoted confidence in our banking system, and protected the deposits of customers and small businesses--not the investments of executives and shareholders.

Thanks to the New Deal and the hard work of our regulators today, most bank failures, while never a good thing, are generally not a big deal.

Monday morning quarterbacking aimed only at the actions of regulators this month is as convenient as it is misplaced, coming from those who have never met a Wall Street wish list they did not want to grant.

That's why I'll be introducing legislation to strengthen regulators' ability to impose fines and penalties, clawback bonuses, and ban executives who caused bank failures from working at another bank ever again.